,
Noordman, Bo Jan
Wijnhoven, Bas P. L.
Lagarde, Sjoerd M.
Boonstra, Jurjen J.
Coene, Peter Paul L. O.
Dekker, Jan Willem T.
Doukas, Michael
van der Gaast, Ate
Heisterkamp, Joos
Kouwenhoven, Ewout A.
Nieuwenhuijzen, Grard A. P.
Pierie, Jean-Pierre E. N.
Rosman, Camiel
van Sandick, Johanna W.
van der Sangen, Maurice J. C.
Sosef, Meindert N.
Spaander, Manon C. W.
Valkema, Roelf
van der Zaag, Edwin S.
Steyerberg, Ewout W.
van Lanschot, J. Jan B.
Funding for this research was provided by:
KWF Kankerbestrijding (10825)
ZonMw (843004104)
Article History
Received: 8 November 2017
Accepted: 23 January 2018
First Online: 6 February 2018
Ethics approval and consent to participate
: The study has been approved by the medical ethics committee of the Erasmus MC (MEC2017–392). Written, voluntary, informed consent to participate in the study will be obtained from participants. Individual patient data will not be made available.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.